Dividend Information About STERIS: Everything You Need To Know Before Its Ex-Dividend Date on Sep 4, 2025
Generated by AI AgentAinvest Dividend Digest
Monday, Sep 1, 2025 1:02 am ET1min read
STE--
Aime Summary
Aime SummarySTERIS (STE) recently announced a cash dividend of $0.630 per share, with the ex-dividend date set for Sep 4, 2025. The dividend was declared on Jul 30, 2025, and will be distributed on Sep 26, 2025. This upcoming payment is higher than the average of the last 10 dividends, which stood at $0.455 per share, indicating a notable increase in the company’s dividend output. The last dividend was paid on Jun 26, 2025, at a rate of $0.570 per share, also in the form of a cash dividend. Investors should note that the ex-dividend date marks the final opportunity to purchase shares and qualify for this dividend payment; any transactions executed after Sep 4, 2025, will not be eligible for the upcoming payout.
Over the past week, STERISSTE-- has seen a mix of developments that may influence its stock performance and long-term trajectory. Recently, analysts have highlighted the company’s strong cash flow and robust fundamentals as key drivers of its market resilience, despite a technically mixed outlook. As of late, KeyBanc reiterated a Buy rating for STESTE-- with a target price of $288.00, reflecting confidence in the company’s growth potential and operational strength. The stock closed at $248.98, suggesting a significant upside from the analyst’s perspective. Additionally, institutional activity has drawn attention, as Russell Investments Group Ltd. recently sold shares of STE on Aug 19, 2025, potentially signaling a strategic rebalancing of its portfolio. Since the last update, STE has outperformed the S&P 500 in 2025 with a 20.9% gain, showcasing its ability to deliver strong returns in a competitive market environment.
In conclusion, STERIS continues to demonstrate solid fundamentals and favorable analyst sentiment, with recent institutional activity and technical indicators adding layers of complexity to its market outlook. The ex-dividend date of Sep 4, 2025, is the last day for investors to purchase shares and qualify for the upcoming dividend; any trades executed after this date will not entitle the buyer to the $0.630 per share payout.
Over the past week, STERISSTE-- has seen a mix of developments that may influence its stock performance and long-term trajectory. Recently, analysts have highlighted the company’s strong cash flow and robust fundamentals as key drivers of its market resilience, despite a technically mixed outlook. As of late, KeyBanc reiterated a Buy rating for STESTE-- with a target price of $288.00, reflecting confidence in the company’s growth potential and operational strength. The stock closed at $248.98, suggesting a significant upside from the analyst’s perspective. Additionally, institutional activity has drawn attention, as Russell Investments Group Ltd. recently sold shares of STE on Aug 19, 2025, potentially signaling a strategic rebalancing of its portfolio. Since the last update, STE has outperformed the S&P 500 in 2025 with a 20.9% gain, showcasing its ability to deliver strong returns in a competitive market environment.
In conclusion, STERIS continues to demonstrate solid fundamentals and favorable analyst sentiment, with recent institutional activity and technical indicators adding layers of complexity to its market outlook. The ex-dividend date of Sep 4, 2025, is the last day for investors to purchase shares and qualify for the upcoming dividend; any trades executed after this date will not entitle the buyer to the $0.630 per share payout.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet